Start-Up Quarterly Statistics, Q2 2012

13 Sep 2012

• By Deanna Kamienski

In the second quarter of 2012, start-up companies raised a total of $556 million across all industries. Most of that financing – $439.8 million – went to the biopharma sector. Cancer was the most prevalent therapeutic area for alliances. There were just four start-up acquisitions – two each in the biopharma and medical device industries.

In the second quarter of 2012, start-ups brought in a total of $556 million in financing across all industries. (See Exhibit 1.) Twenty biopharma companies raised $439.9 million, which was about $102 million more than Q1.

Exhibit 1

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

Start your 7-day free trial
Explore trusted news, analysis, and insights
Access comprehensive global coverage
Enjoy instant access – no credit card required

Start Free Trial

Already a subscriber?

Sarepta Sells Arrowhead Shares To Raise Cash, Pay Arrowhead

14 Aug 2025

• By Mandy Jackson

Sarepta is in a cash crunch with sales of Elevidys slumping due to safety concerns and with financial commitments coming due, including debt repayments and milestone fees for its partner Arrowhead.